Kari Hemminki

A gene-wide investigation on polymorphisms in the taste receptor 2R14 (TAS2R14) and susceptibility to colorectal cancer.

Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control study.

Association between TAS2R38 gene polymorphisms and colorectal cancer risk: a case-control study in two independent populations of Caucasian origin.

A comprehensive investigation on common polymorphisms in the MDR1/ABCB1 transporter gene and susceptibility to colorectal cancer.

Shared ancestral susceptibility to colorectal cancer and other nutrition related diseases.

Single nucleotide polymorphisms within interferon signaling pathway genes are associated with colorectal cancer susceptibility and survival.

Structural chromosomal aberrations as potential risk markers in incident cancer patients.

Interactions of DNA repair gene variants modulate chromosomal aberrations in healthy subjects.

Genetic variation in the major mitotic checkpoint genes associated with chromosomal aberrations in healthy humans.

Genomewide association study on monoclonal gammopathy of unknown significance (MGUS).

Bleomycin-induced chromosomal damage and shortening of telomeres in peripheral blood lymphocytes of incident cancer patients.

Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer.

Short article: Influence of regulatory NLRC5 variants on colorectal cancer survival and 5-fluorouracil-based chemotherapy.

Coding variants in NOD-like receptors: An association study on risk and survival of colorectal cancer.

Genetic variation associated with chromosomal aberration frequency: A genome-wide association study.

Genetic variation of acquired structural chromosomal aberrations.

Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS): comparison with multiple myeloma.

Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival.

Distinct pathways associated with chromosomal aberration frequency in a cohort exposed to genotoxic compounds compared to general population.

Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance.

Epistatic effect of TLR3 and cGAS-STING-IKKε-TBK1-IFN signaling variants on colorectal cancer risk.

Genetic predisposition for multiple myeloma.

TERT promoter mutations in actinic keratosis before and after treatment.

Association between tumor characteristics and second primary cancers with cutaneous melanoma survival: A nationwide cohort study.

Second Primary Cancers in Melanoma Patients Critically Shorten Survival.

Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome Sequencing.

Determining the Appropriate Risk-Adapted Screening Age for Familial Breast Cancer.

Search for multiple myeloma risk factors using Mendelian randomization.

A Germline Mutation in the Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer.

Genomic imprinting analyses identify maternal effects as a cause of phenotypic variability in type 1 diabetes and rheumatoid arthritis.

Familial risks between Graves disease and Hashimoto thyroiditis and other autoimmune diseases in the population of Sweden.

Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an example.

Incidence Differences Between First Primary Cancers and Second Primary Cancers Following Skin Squamous Cell Carcinoma as Etiological Clues.

Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor.

Cancer Predisposition Genes in Cancer-Free Families.

Chromosomal damage and telomere length in peripheral blood lymphocytes of cancer patients.

Familial associations between autoimmune hepatitis and primary biliary cholangitis and other autoimmune diseases.

Familial associations for Addison's disease and between Addison's disease and other autoimmune diseases.

Impact of genetic polymorphisms in kinetochore and spindle assembly genes on chromosomal aberration frequency in healthy humans.

Familial associations for rheumatoid autoimmune diseases.

Familial risks between giant cell arteritis and Takayasu arteritis and other autoimmune diseases in the population of Sweden.

Telomere length in peripheral blood lymphocytes related to genetic variation in telomerase, prognosis and clinicopathological features in breast cancer patients.

A rare large duplication of MLH1 identified in Lynch syndrome.

Familial Risks between Pernicious Anemia and Other Autoimmune Diseases in the Population of Sweden.

Characterization of rare germline variants in familial multiple myeloma.

Whole Exome Sequencing Identifies and Genes as Potentially Cancer Predisposing in Familial Colorectal Cancer.

DNA repair gene polymorphisms and chromosomal aberrations in healthy, nonsmoking population.

Whole Genome Sequencing Prioritizes , and as Possible Predisposition Genes for Familial Non-Medullary Thyroid Cancer.

Polymorphisms within Autophagy-Related Genes Influence the Risk of Developing Colorectal Cancer: A Meta-Analysis of Four Large Cohorts.

A Novel Low-Risk Germline Variant in the SH2 Domain of the SRC Gene Affects Multiple Pathways in Familial Colorectal Cancer.

Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor.

Incidence trends in lung and bladder cancers in the Nordic Countries before and after the smoking epidemic.

Bladder and upper urinary tract cancers as first and second primary cancers.

Family history of early onset acute lymphoblastic leukemia is suggesting genetic associations.

Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden.

DNA Repair Gene Polymorphisms and Chromosomal Aberrations in Exposed Populations.

Search for AL amyloidosis risk factors using Mendelian randomization.

Second Primary Cancers After Gastric Cancer, and Gastric Cancer as Second Primary Cancer.

Survival in colon and rectal cancers in Finland and Sweden through 50 years.

Second Primary Cancers After Kidney Cancers, and Kidney Cancers as Second Primary Cancers.

Combinations of Low-Frequency Genetic Variants Might Predispose to Familial Pancreatic Cancer.

Second Primary Cancers After Liver, Gallbladder and Bile Duct Cancers, and These Cancers as Second Primary Cancers.

Epidemiology, genetics and treatment of multiple myeloma and precursor diseases.

Family History of Head and Neck Cancers.

Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016.

Familial Risks and Proportions Describing Population Landscape of Familial Cancer.

Types of second primary cancer influence overall survival in cutaneous melanoma.

Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden.

Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the Prognosis.

The Asthma Family Tree: Evaluating Associations Between Childhood, Parental, and Grandparental Asthma in Seven Chinese Cities.

Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years.

Functional dissection of inherited non-coding variation influencing multiple myeloma risk.

T- and B-Cells in the Inner Invasive Margin of Hepatocellular Carcinoma after Resection Associate with Favorable Prognosis.

Germline Variants of and Predispose to Familial Colorectal Cancer.

Whole-Exome Sequencing Identifies a Novel Germline Variant in Gene in Familial Colorectal Cancer.

Long-term incidence and survival trends in cancer of the gallbladder and extrahepatic bile ducts in Denmark, Finland, Norway and Sweden with etiological implications related to Thorotrast.

Incidence and survival in oral and pharyngeal cancers in Finland and Sweden through half century.

Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6.

Long-term incidence in hepatocellular carcinoma and intrahepatic bile duct cancer in Denmark, Finland, Norway and Sweden, role of Thorotrast?

Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country.

Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment.

Whole exome sequencing identifies novel germline variants of SLC15A4 gene as potentially cancer predisposing in familial colorectal cancer.

Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study.

Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half century.

Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?

Family history of any cancer for childhood leukemia patients in Sweden.

CTNNB1 mutations, TERT polymorphism and CD8+ cell densities in resected hepatocellular carcinoma are associated with longer time to recurrence.

Genetic signature of differentiated thyroid carcinoma susceptibility: a machine learning approach.

Survival trends in solid cancers in the Nordic countries through 50 years.

Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers.

Monitoring of telomere dynamics in peripheral blood leukocytes in relation to colorectal cancer patients' outcomes.

Survival trends in hematological malignancies in the Nordic countries through 50 years.

Long-term survival trends for primary liver and pancreatic cancers in the Nordic countries.

Long Non-Coding RNA and microRNA Interplay in Colorectal Cancer and Their Effect on the Tumor Microenvironment.

Overview on population screening for carriers with germline BRCA mutation in China.

Incidence, Mortality and Survival Trends in Breast Cancers Coincident with Introduction of Mammography in the Nordic Countries.

Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies.

Author Correction: Functional dissection of inherited non-coding variation influencing multiple myeloma risk.

Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements.

Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma.

An investigation of DNA damage and DNA repair in chemical carcinogenesis triggered by small-molecule xenobiotics and in cancer: Thirty years with the comet assay.

Autoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers in Sweden.

Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century.

Response to letter entitled: Re: Survival trends in solid cancers in the Nordic countries through 50 years.

Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment.

Survival in gastric and esophageal cancers in the Nordic countries through a half century.

Are population level familial risks and germline genetics meeting each other?

GWAS-Identified Variants for Obesity Do Not Influence the Risk of Developing Multiple Myeloma: A Population-Based Study and Meta-Analysis.

Re: Mark N. Brook, Holly Ní Raghallaigh, Koveela Govindasami, et al. Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study. Eur Urol 2023;83:257-66.

Survival in melanoma in the nordic countries into the era of targeted and immunological therapies.

Survival in Lung Cancer in the Nordic Countries Through A Half Century.

Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances.

Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?

Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization.

Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century.

Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers.

Association between intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid (n-3 PUFA DHA) and reduced risk of ovarian cancer: A systematic Mendelian Randomization study.

Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic Countries.

Conditional survival in breast cancer up to 10 years in the Nordic countries.

Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements.

Early mortality critically impedes improvements in thyroid cancer survival through a half century.

Steady survival improvements in soft tissue and bone sarcoma in the Nordic countries through 50 years.

Long-Term Periodic and Conditional Survival Trends in Prostate, Testicular, and Penile Cancers in the Nordic Countries, Marking Timing of Improvements.

Identification of novel genetic loci for risk of multiple myeloma by functional annotation.

miRNA and lncRNA as potential tissue biomarkers in hepatocellular carcinoma.

Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century.

Prognostic role of macrophages and mast cells in the microenvironment of hepatocellular carcinoma after resection.

Genetic And Environmental Associations Of Nonspecific Chromosomal Aberrations.

Major improvement in thyroid cancer survival of elderly patients in the Nordic countries.

Large differencies in age-specific survival in multiple myeloma in the nordic countries.

Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century.

Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis.